After more than a decade in development, a full-spectrum cannabis extract has received market authorisation in Germany and Austria, with UK approval expected by the end…
Cannabis Europa, the leading B2B conference for the European cannabis industry, has announced the full programme for its 2026 London edition. Taking place at The Barbican…
Ananda Pharma has cleared the final regulatory hurdle needed to begin its ENDOCAN Phase 2 clinical trial, receiving approval from the MHRA and NHS Health Research…
